Study Name: PHOTOBIOMODULATION FOR THE MANAGEMENT OF TEMPOROMANDIBULAR DISORDER PAIN
Purpose of the study
Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to assess the use of PMD for TMD pain. Also, we propose to determine if PBM-induced changes in inflammation contribute to PBM’s pain relieving effects. This study is a randomized study (like the flip of a coin) where both the researcher and participant do not know the treatment to test whether PMB can help reduce pain in individuals with TMD.
Who is eligible?
• Participants should be at least 18 years old
• Have a diagnosis of TMD, or
• Have experienced facial pain for at least 3 months
• Study participants will be paid $300 for completing all study activities. A
parking voucher to cover the cost of parking a car will be provided for
each study visit.
What will happen if I participate?
In this study, participants will be randomly assigned to receive either active or
placebo light therapy to determine if TMD pain lessens. The study requires participants to visit the clinic for 7 visits over a period of 3-5 weeks. Each visit will last approximately 1-3 hours.
Please contact the team at 352-273-5857
Principal Investigator: Dr. Margarete Ribeiro-Dasilva
Study Coordinator: Danny Johnson